Authors:
UCKUN FM
SENSEL MG
SATHER HN
GAYNON PS
ARTHUR D
LANGE B
STEINHERZ P
KRAFT P
HUTCHINSON R
NACHMAN J
REAMAN G
HEEREMA NA
Citation: Fm. Uckun et al., CLINICAL-SIGNIFICANCE OF TRANSLOCATION T(1-19) IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA IN THE CONTEXT OF CONTEMPORARY THERAPIES, American journal of human genetics, 61(4), 1997, pp. 469-469
Authors:
STEINHERZ PG
GAYNON PS
BRENEMAN JC
CHERLOW JM
GROSSMAN NJ
KERSEY JH
JOHNSTONE HS
SATHER HN
TRIGG ME
CHAPPELL R
HAMMOND D
BLEYER WA
Citation: Pg. Steinherz et al., CYTOREDUCTION AND PROGNOSIS IN ACUTE LYMPHOBLASTIC-LEUKEMIA - THE IMPORTANCE OF EARLY MARROW RESPONSE - REPORT FROM THE CHILDRENS CANCER GROUP, Journal of clinical oncology, 14(2), 1996, pp. 389-398
Authors:
FEIG SA
AMES MM
SATHER HN
STEINHERZ L
REID JM
TRIGG M
PENDERGRASS TW
WARKENTIN P
GERBER M
LEONARD M
BLEYER WA
HARRIS RE
Citation: Sa. Feig et al., COMPARISON OF IDARUBICIN TO DAUNOMYCIN IN A RANDOMIZED MULTIDRUG TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA AT FIRST BONE-MARROW RELAPSE - A REPORT FROM THE CHILDRENS CANCER GROUP, Medical and pediatric oncology, 27(6), 1996, pp. 505-514
Citation: Bj. Lange et al., RANDOMIZED COMPARISON OF MODERATE-DOSE METHOTREXATE INFUSIONS TO ORALMETHOTREXATE IN CHILDREN WITH INTERMEDIATE RISK ACUTE LYMPHOBLASTIC-LEUKEMIA - A CHILDRENS CANCER GROUP-STUDY, Medical and pediatric oncology, 27(1), 1996, pp. 15-20
Authors:
SHU XO
REAMAN GH
LAMPKIN B
SATHER HN
PENDERGRASS TW
ROBISON LL
Citation: Xo. Shu et al., ASSOCIATION OF PATERNAL DIAGNOSTIC-X-RAY EXPOSURE WITH RISK OF INFANTLEUKEMIA, Cancer epidemiology, biomarkers & prevention, 3(8), 1994, pp. 645-653
Authors:
BUCKLEY JD
BUCKLEY CM
RUCCIONE K
SATHER HN
WASKERWITZ MJ
WOODS WG
ROBISON LL
Citation: Jd. Buckley et al., EPIDEMIOLOGIC CHARACTERISTICS OF CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA- ANALYSIS BY IMMUNOPHENOTYPE, Leukemia, 8(5), 1994, pp. 856-864
Citation: Gs. Gilchrist et al., LOW NUMBERS OF CSF BLASTS AT DIAGNOSIS DO NOT PREDICT FOR THE DEVELOPMENT OF CNS LEUKEMIA IN CHILDREN WITH INTERMEDIATE-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA - A CHILDRENS CANCER GROUP-REPORT, Journal of clinical oncology, 12(12), 1994, pp. 2594-2600
Citation: Ah. Xiang et al., POWER CONSIDERATIONS FOR TESTING AN INTERACTION IN A 2XK FACTORIAL DESIGN WITH A FAILURE TIME OUTCOME, Controlled clinical trials, 15(6), 1994, pp. 489-502
Authors:
GAYNON PS
STEINHERZ PG
BLEYER WA
ABLIN AR
ALBO VC
FINKLESTEIN JZ
GROSSMAN NJ
NOVAK LJ
PYESMANY AF
REAMAN GH
CHAPPELL RJ
SATHER HN
HAMMOND GD
Citation: Ps. Gaynon et al., IMPROVED THERAPY FOR CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA AND UNFAVORABLE PRESENTING FEATURES - A FOLLOW-UP REPORT OF THE CHILDRENS CANCER GROUP-STUDY CCG-106, Journal of clinical oncology, 11(11), 1993, pp. 2234-2242
Citation: Jm. Cherlow et al., THE ROLE OF RADIATION-THERAPY IN THE TREATMENT OF ACUTE LYMPHOBLASTIC-LEUKEMIA WITH LYMPHOMATOUS PRESENTATION - A REPORT FROM THE CHILDRENSCANCER GROUP, International journal of radiation oncology, biology, physics, 27(5), 1993, pp. 1001-1009
Citation: J. Nachman et al., YOUNG-ADULTS 16-21 YEARS OF AGE AT DIAGNOSIS ENTERED ON CHILDRENS CANCER GROUP ACUTE LYMPHOBLASTIC-LEUKEMIA AND ACUTE MYELOBLASTIC-LEUKEMIAPROTOCOLS - RESULTS OF TREATMENT, Cancer, 71(10), 1993, pp. 3377-3385